Vensana Capital β 2025 Investments
7 investments dated 2025 Β· listed companies and verified rows first Β· show all
Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).
BiotechHealthtechMedical DevicesAustin, US
Adam Berman(Executive Officer, Director)Jacob Kriegel(Executive Officer, Director)Avni Patel(Executive Officer, Director)Christopher Alex Arevalos(Executive Officer, Director)Albertien Greijdanus(Executive Officer, Director)
BoardGeoff Pardo(Director)
Board seatKirk NielsenMaria BerkmanΒ· per SEC Form D
Co-investorsBroadview VenturesRiverVest Venture PartnersTMC Venture FundCadence Healthcare VenturesGilde HealthcareGilmartin Capital LLC+1 more
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US
Paul Flook(Executive Officer, Director)Gregory J. Gosch(Executive Officer, Director)Lynne Rollins(Executive Officer)Aditya Rajagopal(Director)Axel Scherer(Director)
Board seatJustin KleinΒ· per SEC Form D
Co-investorsAdjuvant CapitalGlobal BrainMoore Venture PartnersNew Enterprise Associates (NEA)Windham Capital PartnersDomain Associates+2 more
Overnight automated insulin delivery
Wilmington, US
John Sjolund(Chief Executive Officer of the Issuer)Jon Brilliant(Chief Financial Officer of the Issuer)
BoardPeter N. Townsend(Director)
Board seatJustin KleinAmrinder SinghΒ· per SEC Form D
Co-investorsSerpentine Ventures
Okami Medical develops the LOBO vascular occlusion system, an occluder built on high-density, small-pore HDBRAID technology for fast arterial occlusion in the peripheral vasculature, along with SENDERO microcatheters and delivery catheters.
BiotechHardwareHealthtechMedical DevicesAliso Viejo, US
Brian J. Cox(Manager)Rhonda Robb(Executive Officer, Director)Robert Rosenbluth(Director)
BoardDonald Milder(Director)Jonathan Root(Director)inPaul Lubock(Director)
Board seatMike KramerKirk NielsenΒ· per SEC Form D
Co-investorsUS Venture PartnersGilde Healthcare
HealthtechBirmingham, US
Tom Livingston(Executive Officer, Director)Michael Jackson(Executive Officer)Robert E. Foster, M.D.(Executive Officer, Director)
BoardChase Wise(Director)
Board seatMike KramerKirk NielsenΒ· per SEC Form D Β· $21.7M raise Β· filed May 2025
Edina, US
BoardThomas Tu(Executive Officer)inWilliam Hoffman(Executive Officer)inSteven Schwen(Executive Officer)in
Board seatMaria BerkmanKirk NielsenΒ· per SEC Form D Β· $25M raise Β· filed Aug 2025
Luna Diabetes builds an automated insulin delivery system for people with diabetes who use insulin pens (MDI) rather than traditional insulin pumps.
Digital HealthHealthtechMedical Devices
Co-investorsInterlock CapitalSerpentine VenturesWinklevoss Capital
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.